Navigation Links
BIOCOM Response to Health Portion of President's Speech at George Washington University
Date:4/15/2011

SAN DIEGO, April 15, 2011 /PRNewswire/ -- In a speech delivered Wednesday, President Obama outlined a framework for addressing the federal deficit.  Among other issues addressed, the President discussed Medicare and his proposals to decrease its cost.  According to the President, one of his proposals is to "speed generic brands of medicine onto the market."  Many observers believe this was a reference to his continued call to reduce the length of non-patent data exclusivity for new drugs and biologics. "It is unfortunate that the President, who has repeatedly expressed a commitment to biomedical research and the innovation economy, may hinder both by his proposed actions. The Administration apparently fails to recognize in its framework that, absent strong patent protection and adequate data exclusivity provisions for the clinical trial data that cost companies hundreds of millions of dollars to develop, research will not automatically result in commercialization of products," said Joe Panetta, President and CEO of BIOCOM.

"Promising biomedical research that does not ultimately reach the patient in the form of new therapies or devices does an injustice to the American taxpayer, as well as patients," Panetta said. "In passing his Patient Protection and Affordable Care Act in 2010, Congress already overwhelmingly rejected the President's attempts to shorten data exclusivity provisions, recognizing that his proposal would be adverse to the development of important new therapies.  Exciting work in fatal (e.g. cancer) and chronic (e.g. Alzheimer's) diseases would be shelved because the tremendous cost of development would not be recouped.  It is unfortunate the President continues to revisit this issue," Panetta said.

In his remarks, the President also called for expansion of powers for the so-called Independent Payment Advisory Board (IPAB).  "This unelected Board, unaccountable to the American people, can already make wholesale changes to Medicare and the President and Congress have an extremely limited ability to intervene," continued Panetta.  "Any further expansion of the IPAB will fundamentally interfere with a physician's ability to determine what is best for the patient, or for physicians, hospitals, or drug and device manufacturers to have input on fair and reasonable reimbursement. The life sciences industry will already be contributing a great deal to health reform, well over $100 billion by some estimations.  Given that many studies place the prescription drug and prescription medical device industries combined as less than 15% of the total health care dollar, the industry already is being a responsible partner in doing its share.  Several lawmakers have already weighed in with their concerns about the expansion of powers of IPAB, and BIOCOM echoes those concerns."

About BIOCOM: BIOCOM is the largest regional life science association in the world, representing more than 550 member companies in Southern California. The association focuses on initiatives that positively influence the region's life science community in the development and delivery of innovative products that improve health and quality of life. This includes initiatives in capital formation, public policy, workforce development, group purchasing and member services such as networking events. For more information on BIOCOM or the Southern California biotechnology and medical device community, please visit www.biocom.org.


'/>"/>
SOURCE BIOCOM
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable
2. Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference
3. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
5. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
6. ISTA Pharmaceuticals to Present at 2009 BIOCOM Investor Conference
7. Digirad Corporation to Present at BIOCOM 4th Annual Investor Conference
8. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
9. Adnavance Technologies to Present Initial Data Supporting Direct Detection Molecular Diagnostic Tests at AdvaMed 2009 and BIOCOM Investor Conference
10. BIOCOMs 4th Annual DeviceFest Honors Companies
11. Lilly Receives Complete Response Letter From FDA for Liprotamase for the Treatment of Exocrine Pancreatic Insufficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... , Feb. 9, 2016   AllCare Plus Pharmacy ... Commission,s Gold Seal of Approval ® for ... its performance standards. The Gold Seal of Approval ® ... organization,s commitment to providing safe and effective care.  ... Plus Pharmacy underwent a rigorous on-site survey in January ...
(Date:2/9/2016)... Hearing protection devices refer to the barriers ... the inner ear. Hearing protection devices include earplugs, uniform ... recommended for users exposed to noise levels of over ... that are inserted in the ear canal to protect ... more natural sound perception with the help of acoustic ...
(Date:2/9/2016)... The new report "Global Blood Monitoring & Cardiac Monitoring Devices Market ... group reveals that global market for blood monitoring & cardiac monitoring ... to grow to US$ 24,830.1 million by 2019 at a CAGR ... , Europe , Asia-Pacific ... and Africa . The three major factors ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... February 10, 2016 , ... The Journal of Pain ... “level the playing field .” , As corresponding author Dr John F. Peppin says ... categorize and diagnose our chronic pain patients. ‘Chronic cancer pain’ and ‘chronic non-cancer ...
(Date:2/9/2016)... Palm City, Florida (PRWEB) , ... February 09, ... ... providers of cold therapy products, announced today the introduction of the newly designed, ... for maximum comfort and better cold therapy coverage for the injured arm and ...
(Date:2/9/2016)... St. Petersburg, FL (PRWEB) , ... February 09, 2016 , ... Shark Finds ... of a new DRTV campaign with GRIP-DRY. , GRIP-DRY is a newly patented product that ... carts. Golfers who play in the wet and early morning dew or right after a ...
(Date:2/8/2016)... ... February 08, 2016 , ... Coast Dental has a new way ... Dental Health Month and family dentist Yvonne Dorrian, DMD, is hosting a free seminar ... , located next to Target at 1207 North Peachtree Parkway in Peachtree City. Dr. ...
(Date:2/8/2016)... ... 2016 , ... If you are feeling that your clothes are a tad ... to the Center for Disease Control and Prevention (CDC), 34.9% of U.S. adult women ... of cancer, some of the leading causes of preventable death. February is heart ...
Breaking Medicine News(10 mins):